Anti-uPA Receptor/U-PAR 抗体 (ab3129)

Submit a review Q&A (3)References (3)

Key features and details

  • Goat polyclonal to uPA Receptor/U-PAR
  • Reacts with: Human
  • Isotype: IgG

製品の概要

  • 製品名

    Anti-uPA Receptor/U-PAR antibody
    uPA Receptor/U-PAR 一次抗体 製品一覧

  • 製品の詳細

    Goat polyclonal to uPA Receptor/U-PAR

  • 由来種

    Goat

  • 種交差性

    交差種: Human

  • 免疫原

    Recombinant full length protein corresponding to Human uPA Receptor/U-PAR.

  • 特記事項

    Reproducibility is key to advancing scientific discovery and accelerating scientists’ next breakthrough.

    Abcam is leading the way with our range of recombinant antibodies, knockout-validated antibodies and knockout cell lines, all of which support improved reproducibility.

    We are also planning to innovate the way in which we present recommended applications and species on our product datasheets, so that only applications & species that have been tested in our own labs, our suppliers or by selected trusted collaborators are covered by our Abpromise™ guarantee.

    In preparation for this, we have started to update the applications & species that this product is Abpromise guaranteed for.

    We are also updating the applications & species that this product has been “predicted to work with,” however this information is not covered by our Abpromise guarantee.

    Applications & species from publications and Abreviews that have not been tested in our own labs or in those of our suppliers are not covered by the Abpromise guarantee.

    Please check that this product meets your needs before purchasing. If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, as well as customer reviews and Q&As.

製品の特性

ターゲット情報

  • 機能

    Acts as a receptor for urokinase plasminogen activator. Plays a role in localizing and promoting plasmin formation. Mediates the proteolysis-independent signal transduction activation effects of U-PA. It is subject to negative-feedback regulation by U-PA which cleaves it into an inactive form.

  • 組織特異性

    Expressed in neurons of the rolandic area of the brain (at protein level). Expressed in the brain.

  • 配列類似性

    Contains 3 UPAR/Ly6 domains.

  • 細胞内局在

    Secreted and Cell membrane.
  • Information by UniProt

  • 参照データベース

    • 別名

      • CD 87 antibody
      • CD87 antibody
      • CD87 antigen antibody
      • MO 3 antibody
      • MO3 antibody
      • Monocyte activation antigen Mo3 antibody
      • Plasminogen activator receptor urokinase antibody
      • Plasminogen activator urokinase receptor antibody
      • PLAUR antibody
      • U PAR antibody
      • u plasminogen activator receptor antibody
      • U-PAR antibody
      • u-plasminogen activator receptor form 2 antibody
      • UPA receptor antibody
      • uPAR antibody
      • UPAR_HUMAN antibody
      • Urinary plasminogen activator receptor antibody
      • URKR antibody
      • Urokinase plasminogen activator receptor antibody
      • Urokinase plasminogen activator surface receptor antibody
      • urokinase-type plasminogen activator (uPA) receptor antibody
      see all

    参考文献 (3)

    ab3129 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

    ab3129 は 3 報の論文で使用されています。

    • Pavet V  et al. Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells. Cell Death Dis 5:e1043 (2014). WB . PubMed: 24481457
    • Al-Souhibani N  et al. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes. Oncogene : (2010). WB ; Human . PubMed: 20498646
    • Bezuidenhout L  et al. Ang-2 and PDGF-BB cooperatively stimulate human peripheral blood monocyte fibrinolysis. J Leukoc Biol 81:1496-503 (2007). Neutralising ; Human . PubMed: 17395886

    レビューと Q&A

    Show All レビュー Q&A
    レビューを送る 質問を送る

    1-3 of 3 Abreviews or Q&A

    Question

    Thank you for kindly reply. I measured annexin v and Propidium Iodide(PI) in FACS, about 90 % cells were PI staining positive. So I considered cells were necrosis, moreover under the microscope cells are detached and morphological change occur and no fungus/bacteria contamination were obvious. According to your advice we use 0.5 ug/ml  concentration because when I used this concentration %PI positive cells was normal distribution. And I could not find answer of the last question about this product. Are there no changes in this product from 2007 to present? Sincerely yours  

    Read More
    Answer

    Thank you for your email. The lot number customer used in 2007 was different than you have been using. So we would expect some variations due to cell line or other lab related factors. I can assure you that there is no change in the antibody itself other than difference in lot. We are also not sure whether this antibody has any lot related issues, so I am sorry I am unable to comment on this. I would also like to ask is this antibody able to neutralize the effect of uPA? I hope this information will help. Should you have any other question please do not hesitate to ask.

    Read More

    Question

    Dear Sir/Madam I purchased your product  "uPA receptor antibody cat.no, ab3129". I used this antibody in order to neutralize uPA receptor, so I added this antibody into culture medium for 24 hrs. I cultured human pulmonary artery smooth muscle cells (invitrogen) in 0.5 % fcs/Medium231(invitrogen). Then I measured apoptosis using annexin v and staining method by FACS. Surprisingly when I added 2-4ug/ml concentration of this antibody, cells were almost died. So, I have a question. Is this antibody have cell toxicity component? According to reference that was mentioned in datasheet "Bezuidenhout L et al. Ang-2 and PDGF-BB cooperatively stimulate human peripheral blood monocyte fibrinolysis. J Leukoc Biol 81:1496-503 (2007)" , cells was not died. But this paper was published 2007 ,are there any changes in this product from 2007 to present? And when I use 0.5ug/ml concentration of this product, cells were alive. Can I use this concentration as blocking uPA receptor?                

    Read More
    Answer

    Thank you for contacting us. Could you specify are the cells just dying or there is some kind of fungus or bacterial growth? The antibody solution only contain sodium azide as cytotoxic compound however the affect of this would be minimal at the Abcam recommended dilutions. The recommended concentration and dilutions to use is between 2-4 ug/ml. However this is for guideline purpose only. The dilutions have to be determined by end user because the conditions vary from cells to cells. We would recommend using a range of dilution e.g. 0.5 ug/ml, 1 ug/ml and 2 ug/ml in order to get optimized neutralization in the cell line you have been using. I hope this information is helpful to you. Please do not hesitate to contact us if you need any more advice or information.

    Read More

    Question

    Could you help recommend a standard/positive control for uPAR run on an SDS-PAGE gel? Our customer is running homogenized mouse skeletal muscle. Thanks!

    Read More
    Answer

    Thank you for your enquiry. Ab3129 has not yet been tested for cross-reactivity with mouse uPA, so I would suggest a control from human samples. For example, uPA and uPAR are known to be overexpressed in mesenchymal and epithelial tumor cells. If you have any additional questions, please contact us again.

    Read More

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com